j.erdogan
TL2 Moderator · Kolkata
Contributes reviews on supplier material. Based in Kolkata.
Joined 5 August 2025 · last posted 7d
71 posts, newest first. Showing up to 150.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #78 · Analytics › Home & field testing · 21 Jul 2026 · 2 likes I read post #76 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #61 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 24 likes I read post #59 twice before replying, because I had assumed the opposite. On integration: where the baseline is drawn matters more than most people realise. On a clean…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #6 · Clinical › Bloodwork · 16 Jul 2026 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
How much context is too much context in a first post? Replied, post #69 · Start Here › How to Ask · 10 Jul 2026 · 8 likes Worth separating two things that post #65 runs together. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #141 · Practice › Interactions · 6 Jul 2026 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #62 · Analytics › Impurities & related substances · 30 Jun 2026 · 0 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Asking a follow-up: new topic or new reply? Replied, post #27 · Start Here › How to Ask · 27 Jun 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #50 · Evidence › Journal club · 25 Jun 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Revisiting: The best-written scientific paper you have read Replied, post #41 · Lounge › Off topic · 20 Jun 2026 · 32 likes post #40 answers the question as asked. The question underneath it is different. Personal stories: if you want to talk about what led you to this compound, your…
-
Prescription requirements and telehealth models — a second dataset Replied, post #67 · Sourcing › Regulatory · 16 Jun 2026 · 17 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #26 · Pharmacology › Pharmacokinetics · 16 Jun 2026 · 20 likes post #25 is right about the mechanism and I think understates the practical bit. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #71 · Devices › Syringes & needles · 13 Jun 2026 · 3 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #100 · Practice › Storage & stability · 8 Jun 2026 · 5 likes This follows post #97 rather than contradicting it. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint…
-
Forced degradation studies: designing one that is informative Replied, post #72 · Analytics › Method validation · 8 Jun 2026 · 4 likes post #71 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #4 · Research Methods › N-of-1 designs · 7 Jun 2026 · 4 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #62 · Sourcing › Red flags · 5 Jun 2026 · 0 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
Shakes versus food: a pragmatic assessment Replied, post #14 · Nutrition & Training › Protein & intake · 4 Jun 2026 · 0 likes I read post #12 twice before replying, because I had assumed the opposite. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #20 · Sourcing › Payments · 28 May 2026 · 2 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
Reading a trial's population section before its results Replied, post #51 · Evidence › Trials · 25 May 2026 · 4 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Revisiting: Mobile reading experience on long topics Replied, post #5 · Meta › Site feedback · 6 May 2026 · 18 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #42 · Clinical › Comorbidities · 5 May 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #26 · Practice › Reconstitution · 26 Apr 2026 · 0 likes post #25 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #118 · Practice › Reconstitution · 25 Apr 2026 · 2 likes post #117 is right about the mechanism and I think understates the practical bit. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #13 · Data & Tools › Calculators · 2 Apr 2026 · 4 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #22 · Evidence › Journal club · 23 Mar 2026 · 16 likes post #21 is right about the mechanism and I think understates the practical bit. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #45 · Practice › Reconstitution · 17 Mar 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A promotion I argued against, and why I lost — a second dataset Replied, post #2 · Documentation › Doc review · 11 Mar 2026 · 11 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Angle of injection and whether 90 degrees is always right Replied, post #89 · Practice › Administration · 26 Jan 2026 · 2 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What to include when your question involves a chromatogram Replied, post #32 · Start Here › How to Ask · 10 Jan 2026 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
The headache that turns out to be dehydration Replied, post #117 · Nutrition & Training › Hydration & electrolytes · 31 Dec 2025 · 12 likes Worth separating two things that post #113 runs together. Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable…
-
DXA precision and the least significant change for lean mass Replied, post #68 · Outcomes › Body composition · 14 Dec 2025 · 5 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Reading SURMOUNT-1 without the press release Replied, post #91 · Compounds › Tirzepatide · 6 Dec 2025 · 18 likes Coming back to post #89, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
Reading SURMOUNT-1 without the press release Replied, post #74 · Compounds › Tirzepatide · 22 Nov 2025 · 31 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Availability by country, dated, with primary sources Replied, post #57 · Access › International · 12 Nov 2025 · 1 like I read post #55 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #50 · Analytics › Home & field testing · 10 Nov 2025 · 0 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
When to stop reading forums, including this one Replied, post #42 · Wellbeing › Mental health · 28 Oct 2025 · 0 likes Picking up post #39: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #3 · Practice › Administration · 28 Oct 2025 · 31 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Substitution between formats during a shortage Replied, post #78 · Access › Shortages · 19 Oct 2025 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Where to report an adverse event officially, by region — a second dataset Started this topic · Safety › Adverse events · 5 Oct 2025 · 16 likes On the subject in the title: Where to report an adverse event officially, by region — a second dataset Working notes rather than a conclusion. Asking about a population…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes On post #63 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #59 · Data & Tools › Datasets · 8 Sep 2025 · 18 likes Picking up post #56: that is the part I would want checked first. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #9 · Practice › Interactions · 28 Aug 2025 · 13 likes post #8 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are taking…
-
Asking about a compound your prescriber has not heard of Replied, post #120 · Clinical › Prescriber conversations · 9 Aug 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Comparing my trajectory with the trial curves, carefully Replied, post #32 · Outcomes › Progress reports · 5 Aug 2025 · 20 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
How to research a compound with no human data without deceiving yourself Replied, post #51 · Compounds › Other compounds · 1 Aug 2025 · 1 like Worth separating two things that post #47 runs together. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #27 · Compounds › Secretagogues & GH axis · 1 Aug 2025 · 4 likes Worth separating two things that post #23 runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for…
-
When a preprint is the best available evidence and we say so Replied, post #5 · Evidence › Preprints · 28 Jul 2025 · 1 like post #4 answers the question as asked. The question underneath it is different. What changes between preprint and publication: authors respond to reviewer comments,…
-
Are there stupid questions here? A staff answer, at length Replied, post #14 · Start Here › Welcome · 26 Jul 2025 · 13 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #63 · Compounds › Semaglutide · 10 Jul 2025 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent…
-
Triple agonism: additive, synergistic, or neither? Replied, post #63 · Compounds › Retatrutide · 2 Jul 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Repeatability versus intermediate precision Replied, post #114 · Analytics › Method validation · 1 Jul 2025 · 7 likes Picking up post #111: that is the part I would want checked first. Range: the concentration range over which the method has been validated. Going outside the validated…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #71 · Compounds › Retatrutide · 17 Jun 2025 · 23 likes post #70 is right about the mechanism and I think understates the practical bit. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Research-use-only labelling: what it means and what it does not Replied, post #3 · Sourcing › Regulatory · 12 Jun 2025 · 14 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Coming back to: Official shortage notices and what they authorise Replied, post #18 · Access › Shortages · 31 May 2025 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Pre-registering a personal experiment, seriously Replied, post #54 · Research Methods › N-of-1 designs · 30 May 2025 · 6 likes Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to do with these compounds (the appetite suppression is hard…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #16 · Devices › Syringes & needles · 30 Apr 2025 · 4 likes I read post #14 twice before replying, because I had assumed the opposite. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
Coming back to: Cross-border purchase rules within the EU Started this topic · Regional › European Union · 22 Mar 2025 · 54 likes Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork…
-
Criticising the method without criticising the authors Replied, post #38 · Evidence › Study critique · 9 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Protein density versus volume when you cannot eat much Replied, post #13 · Nutrition & Training › Protein & intake · 24 Jan 2025 · 11 likes Coming back to post #11, because the follow-up matters more than the original answer. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #93 · Compounds › Tirzepatide · 31 Dec 2024 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Building a sensible monitoring schedule with your prescriber Replied, post #76 · Clinical › Bloodwork · 21 Dec 2024 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #27 · Evidence › Journal club · 13 Dec 2024 · 11 likes I read post #25 twice before replying, because I had assumed the opposite. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
-
Body image changing more slowly than the body Replied, post #18 · Wellbeing › Mental health · 12 Dec 2024 · 17 likes On post #14 — agreed on the reasoning, with one qualification. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status…
-
Gallbladder disease risk with rapid weight loss Replied, post #35 · Clinical › Comorbidities · 24 Nov 2024 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
EMA product information as a primary source — does this still hold? Replied, post #19 · Regional › European Union · 15 Nov 2024 · 2 likes This follows post #16 rather than contradicting it. France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #2 · Compounds › Repair & healing peptides · 10 Nov 2024 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #40 · Clinical › Prescriber conversations · 7 Nov 2024 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Time to steady state after a dose increase Replied, post #153 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 20 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Started this topic · Compounds › Tirzepatide · 16 Oct 2024 · 15 likes Tirzepatide's shorter half-life and its one practical consequence Writing it up because I had to work it out twice and would rather nobody else did. I have seen…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #2 · Compounds › Semaglutide · 8 Aug 2024 · 9 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #3 · Practice › Dosing & titration · 19 May 2024 · 4 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…